Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025

Published Date: 2019-08-28   |   Pages: 102   |   Tables: 123   | Report Id: 1243625   | Hits: 99 |   Pharma & Healthcare

category cover

In 2018, the global Induced Pluripotent Stem Cells market size was 71.7 million US$ and it is expected to reach 160.9 million US$ by the end of 2025, with a CAGR of 12.23% during 2019-2025.

This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study

Fujifilm Holding Corporation (CDI)


Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology


Market segment by Type, the product can be split into

Human iPSCs

Mouse iPSCs

Market segment by Application, split into

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine


Market segment by Regions/Countries, this report covers

United States




Southeast Asia


Central & South America

Other Regions

Licenses Type

Only one user can access the report
Multiple users can access the report


 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Induced Pluripotent Stem Cells market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...